ET
NVS icon

Entropy Technologies’s Novartis NVS Stock Holding History

Entropy Technologies’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.73M Buy
36,558
+24,199
+196% +$3.63M 0.23% 128
2026
Q1 		$1.89M Buy
+12,359
New +$1.89M 0.09% 298
2025
Q1 		– Sell
-9,938
Closed -$967K – 900
2024
Q4 		$967K Buy
+9,938
New +$1.06M 0.1% 281

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Entropy Technologies's NVS Position: Q2 2026 in Review

Entropy Technologies increased its Novartis (NVS) stake by 196% in Q2 2026, buying an estimated $3.63M and bringing the position to 36,558 shares worth $5.73M. The position accounts for 0.23% of the portfolio, ranked #128.

Entropy Technologies first reported a position in NVS in Q4 2024 and has held it in 3 quarters since. 1,621 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Entropy Technologies held 36,558 shares of Novartis worth $5.73M as of Q2 2026.
  • Entropy Technologies bought 24,199 Novartis shares in Q2 2026, an estimated $3.63M.
  • Novartis made up 0.23% of Entropy Technologies's portfolio in Q2 2026, its #128 holding.
  • Entropy Technologies first reported a position in Novartis in Q4 2024 and has held it in 3 quarters since.
  • 1,621 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.